Sharechat Logo

While you were sleeping: European stocks climb

Tuesday 27th May 2014

Text too small?

Equities in Europe advanced after European Central Bank President Mario Draghi cemented expectations euro-zone policy makers will take action at their next meeting in June to help bolster the region’s economy.

Speaking at an ECB Forum on Central Banking on Monday, Draghi said the central bank expects that “low inflation will be prolonged but gradually return to 2 percent.”

“Our responsibility is nonetheless to be alert to the risks to this scenario that might emerge and prepared for action if they do,” Draghi said. “What we need to be particularly watchful for at the moment is the potential for a negative spiral to take hold between low inflation, falling inflation expectations and credit, in particular in stressed countries.”

“And at this point, for monetary policy to produce its full effects, there must be no binding constraints on credit supply through the banking system,” Draghi said. “If, in this context, availability of term funding is a limiting factor on loan origination, then monetary policy can play a bridging role. Term-funding of loans, be it on-balance sheet—that is, through refinancing operations—or off-balance sheet—that is, through purchases of asset-backed securities—could help reduce any drag on the recovery coming from temporary credit supply constraints.”

Europe’s Stoxx 600 Index finished the session with a 0.6 percent increase from the previous close. France’s CAC 40 rose 0.8 percent, while Germany’s DAX climbed 1.3 percent to a fresh record high. London stock and commodities markets were closed for a bank holiday.

“European stocks are pushing higher on the back of investors’ anticipation that the ECB will have to announce stimulus measures at their June 5 meeting,” Benedict Goette, chief executive officer of Compass Capital in Zurich, told Bloomberg News. “We believe this market strength might well continue into early June.”

Investors were also pleased with the outcome of European Parliament elections, held on Sunday, as anti-European Union parties garnered less support than some had feared particularly in key countries Germany and Italy.

Italy’s FTSE MIB index jumped 3.6 percent, while yields on the country’s 10-year bond shed 17 basis points to 2.99 percent

"We have not seen spectacular outcomes in terms of Eurosceptic parties in the weaker countries except for Greece ... and that seems enough to draw investors back," Christian Lenk, a fixed income strategist at DZ Bank, told Reuters.

US markets were closed on Monday for the Memorial Day holiday.

Pfizer said it gave up its effort to buy the UK’s AstraZeneca, which had rejected its latest 69-billion-pound offer.

“We continue to believe that our final proposal was compelling and represented full value for AstraZeneca based on the information that was available to us,” Ian Read, CEO of Pfizer, said in a statement. “As we said from the start, the pursuit of this transaction was a potential enhancement to our existing strategy. We will continue our focus on the execution of our plans, bringing forth new treatments to meet patients’ needs and remaining responsible stewards of our shareholders’ capital.”

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors